Alnara Therapeutics
Latest round
- Series B
Last raised
- Jan 2010
Total raised
- $55M
Investors
- 5
About Alnara Therapeutics
Alnara Therapeutics Inc.Founded in 2008 and headquartered in Cambridge, US, Alnara Therapeutics is engaged in the development of therapeutic solutions.com specializes in the sale and leasing of domain names, offering a streamlined platform for users to acquire digital real estate.com, available for a purchase price of USD 9,995 or through a Lease to Own option priced at USD 480 monthly. This service targets a diverse clientele, including entrepreneurs, small businesses, and larger corporations looking to establish or enhance their online presence. The transaction process is designed to be user-friendly, ensuring that customers can navigate through secure payments and local currency options at checkout.com is driven primarily by the direct sale and leasing of domain names, with transactions occurring through clear pricing structures. Customers can choose between one-time payments for outright purchase or opt for a monthly leasing plan, allowing for flexibility in financial commitment. Each transaction is supported by a commitment to secure payments and hassle-free transfers, enhancing customer confidence and satisfaction.com, and the pricing structure reflects a premium market position, catering to businesses looking for high-value digital assets. In July 2010, the definitive acquisition agreement with Eli Lilly & Co. positions Alnara Therapeutics to potentially develop new therapeutic products that address metabolic diseases. The firm aims to strengthen its presence in both existing and emerging markets, ensuring a broader reach for its solutions. Future product launches are anticipated, although specific details and dates have yet to be disclosed.
Who invested in Alnara Therapeutics
5 investors across 2 rounds
See all investors in Alnara Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alnara Therapeutics
Who invested in Alnara Therapeutics?
Alnara Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alnara Therapeutics raised?
Alnara Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Alnara Therapeutics last raise money?
Alnara Therapeutics's most recent round on record is a Series B, in Jan 2010.
What does Alnara Therapeutics do?
Alnara Therapeutics is a pharmaceuticals company.
Where is Alnara Therapeutics headquartered?
Alnara Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Alnara Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Alnara Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Alnara Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.